Christopher Alan Giuliano

Christopher Alan Giuliano, PharmD, MPH, serves as Clinical Professor of Pharmacy Practice at Wayne State University's Eugene Applebaum College of Pharmacy and Health Sciences and as Internal Medicine Clinical Specialist at St. John Hospital and Medical Center. His academic progression includes Assistant Professor (2010-2016), Associate Professor (2016-2022), and current Professor (2022-present) positions at Wayne State University.

His educational background includes:

• Master of Public Health (MPH), Wayne State University (2017)
• PharmD, University of Toledo (2008)
• B.S. in Pharmaceutical Sciences, University of Toledo (2006)

Dr. Giuliano's research centers on internal medicine pharmacotherapy and health systems outcomes, with particular emphasis on anticoagulation management in complex populations. His work addresses critical challenges in venous thromboembolism treatment, obesity-related dosing, and renal impairment considerations, often through multicenter collaborations that translate evidence into practice.

Analysis of his 2022-2025 publications reveals a concentrated focus on anticoagulation therapy optimization in special populations, with significant contributions to understanding direct oral anticoagulant use in severe obesity, renal dysfunction, and acute kidney injury. His research portfolio also spans infectious disease pharmacotherapy, medication safety systems, and innovative pharmacy education methodologies.

Professional recognition includes:

• SMSHP Preceptor of the Year (2021)

Dr. Giuliano directs the Health Systems Outcomes Research Fellowship and serves as Michigan ACC-CV Team Representative. He leads the ASCEND-HIGHER Research Initiative, a multicenter collaboration evaluating anticoagulation outcomes in high-risk populations across three major health systems. His grant-funded work frequently examines real-world drug therapy effectiveness through electronic health record analyses.

He maintains active involvement with the ASCEND-HIGHER Research Initiative team, which conducts large-scale observational studies on anticoagulation safety and efficacy in diverse patient populations through integrated health system data networks.